Actimaba Program Expansion News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Actimaba Program Expansion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Actimaba Program Expansion Today - Breaking & Trending Today

Actinium Pharma Presents Survival Data from Extended Follow-Up from Actimab-A + CLAG-M Trial and Preclinical Data Supporting Program Expansion with FLT3 Inhibitor Combinations at SOHO

Published: September 7, 2023

/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...

Source: prnewswire.com

Related Topics:

Astellas PharmaSandesh SethMatthew BeckPrnewswire Actinium Pharmaceuticals IncOncology Lg Chem Life SciencesActinium Pharmaceuticals IncActimaba Program ExpansionInvestor Relations CommunicationsExchange CommissionActimaba National Cancer InstituteSociety Of Hematologic OncologyHematologic OncologyStudy ResultsOverall SurvivalDeep ResponsesProlonged SurvivalAdverse Risk Acute Myeloid LeukemiaReceived Prior VenetoclaxActinium ChairmanProgram ExpansionAntileukemic ActivityPreclinical ModelNational Cancer InstituteLife SciencesActinium Pharmaceuticals